EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting ...

Alphabet revenue misses expectations, Robinhood Markets says Super Bowl bets are off, and more news to start your day.

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

A new artificial intelligence model developed by Stanford Medicine combines clinical notes and pathology images to predict ...

February 11 to 13, 2025 Generative AI for Automotive Munich, Germany February 11 to 13, 2025 Data Management for Generative AI in Automotive - 10% Discount: UNITEAI Munich, Germany ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.